相关实验视频
Updated: May 11, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
脂酸在与代谢功能障碍相关的脂肪性肝病中:一篇综述
Fangli Liu1, Jingjing Lv1, Yuanyuan Chen2,3
1School of Nursing and Health, Henan University, Kaifeng, 475004, China.
与代谢功能障碍相关的脂肪性肝病 (MASLD) 在全球范围内正在上升. 脂酸 (LA) 通过各种机制减少肝脏脂肪积累,在预防和缓解MASLD方面表现有前途.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
- 营养科学 营养科学
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个日益严重的全球健康问题.
- MASLD可能会发展为严重的肝脏疾病,如肝硬化和癌症.
- 目前对MASLD有效的药理治疗方法有限.
研究的目的:
- 审查关于脂酸 (LA) 和MASLD之间的关系的最新证据.
- 概述LA影响肝脂积累的机制.
- 突出LA在预防和管理MASLD方面的潜力.
主要方法:
- 对研究脂肪酸 (LA) 和与代谢功能障碍相关的脂肪性肝病 (MASLD) 的文献综述.
- 在各种实验模型中分析LA的影响,包括不同的饮食干预措施和遗传/糖尿病状况.
- 关键分子机制的总结,重点关注线粒体功能,炎症和氧化应激.
主要成果:
- 酸 (LA) 补充剂在多个MASLD模型中已证明有效缓解肝肥胖症.
- 在各种条件下,LA有效地抑制了肝脏中的脂质沉积,包括高脂肪/高果糖饮食和胆缺乏.
- 关键机制包括改善线粒体功能,减少炎症和减轻氧化应激.
结论:
- 脂酸 (LA) 对代谢功能障碍相关的脂肪性肝病 (MASLD) 具有显著的预防作用.
- LA对脂质代谢,线粒体健康和氧化应激的多方面的作用使其成为一个有前途的治疗剂.
- 需要对LA进行进一步的临床研究,以预防和治疗MASLD.
更多相关视频
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
相关概念视频
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Lipid Catabolism
Cirrhosis II: Pathophysiology